Medcaw Investments Past Earnings Performance
Past criteria checks 0/6
Medcaw Investments's earnings have been declining at an average annual rate of -218%, while the Capital Markets industry saw earnings growing at 16.3% annually.
Key information
-218.0%
Earnings growth rate
-197.9%
EPS growth rate
| Capital Markets Industry Growth | 16.3% |
| Revenue growth rate | n/a |
| Return on equity | -32.9% |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Medcaw Investments makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 0 | 0 | 0 | 0 |
Quality Earnings: MCI is currently unprofitable.
Growing Profit Margin: MCI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if MCI's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare MCI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MCI is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (-5.9%).
Return on Equity
High ROE: MCI has a negative Return on Equity (-32.86%), as it is currently unprofitable.